References
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 16:07
References
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 15:57
References
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 15:48
References
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 15:41
Editor's Note
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 15:28
Disclosures
Submitted by mphilemon@resea... on Fri, 04/20/2012 - 15:24
Disclosures:
DEMO - RTP LIBRARY
Submitted by web@researchtop... on Wed, 04/18/2012 - 16:36
DEMO - Blog content
Submitted by web@researchtop... on Wed, 04/18/2012 - 16:21
DEMO - blog
Submitted by web@researchtop... on Wed, 04/18/2012 - 16:19
Consensus or Controversy, Issue 5: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Fri, 04/06/2012 - 14:12
Editor's Note
Submitted by web@researchtop... on Tue, 04/03/2012 - 16:23
Patterns of Care in Breast Cancer — Interactive Edition: Adjuvant chemotherapy for ER-positive, HER2-negative tumors
Disclosures
Submitted by web@researchtop... on Tue, 04/03/2012 - 11:22
Recently Available and Emerging Systemic Treatments for Prostate Cancer
Submitted by mphilemon@resea... on Wed, 03/28/2012 - 14:21
References
Submitted by web@researchtop... on Tue, 03/27/2012 - 17:23
References:
Ademuyiwa FO et al. The effects of Oncotype DX Recurrence Scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat 2011;126(3):797-802. Abstract
Consensus or Controversy, Issue 4: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Submitted by web@researchtop... on Mon, 03/26/2012 - 12:33